Zealand Pharma (ZEAL) receives first FDA approval and prepares for launch of Zegalogue injection

Go back to Zealand Pharma (ZEAL) receives first FDA approval and prepares for launch of Zegalogue injection

Zealand Pharma receives first FDA approval and prepares for launch of Zegalogue® (dasiglucagon) injection

May 12, 2021 9:00 AM EDT

Company announcement No. 29/ 2021

Interim report for Q1 2021

Zealand Pharma receives first FDA approval and prepares for launch of Zegalogue® (dasiglucagon) injection

Financial results for the first quarter of 2021

Revenue: DKK 47.8 million / USD 7.5 million (DKK 12.4 million / USD 1.8 million in the first three months of... More